Related Experiment Video
Updated: Aug 14, 2025

Generation of Murine Cardiac Pacemaker Cell Aggregates Based on ES-Cell-Programming in Combination with Myh6-Promoter-Selection
Published on: February 17, 2015
Pacemaker implantation for persistent sinus node dysfunction in a patient with COVID-19
Tsuyoshi Ota1, Katsunori Okajima1, Yuichi Nagamatsu1
1Department of Cardiology Kakogawa Central City Hospital Kakogawa Japan.
Insights
A patient with coronavirus disease-2019 developed sinus bradycardia and heart failure. Pacemaker implantation was required due to persistent symptoms unresponsive to medical therapy, highlighting a rare cardiac complication of COVID-19.
Area of Science:
- Cardiology
- Infectious Diseases
- Critical Care Medicine
Background:
- Coronavirus disease-2019 (COVID-19) is a global pandemic with diverse clinical manifestations.
- Cardiac complications, including arrhythmias and heart failure, have been reported in COVID-19 patients.
- Sinus bradycardia is an uncommon but significant cardiac finding in the context of severe infections.
Observation:
- A 46-year-old woman with COVID-19 presented with symptomatic sinus bradycardia.
- The bradycardia progressed, leading to congestive heart failure.
- Standard medical therapies (isoproterenol, theophylline, cilostazol) were ineffective and deemed unsafe.
Findings:
- The patient required permanent pacemaker implantation 53 days after initial admission.
- Atrial pacing was utilized, with 60% pacing noted at the 6-month follow-up.
- This case illustrates a severe, refractory bradyarrhythmia secondary to COVID-19 infection.
Implications:
- COVID-19 can precipitate severe cardiac dysfunction, including persistent bradycardia requiring device implantation.
- Careful cardiac monitoring and management are crucial for patients with COVID-19 and cardiac symptoms.
- This case underscores the need for considering advanced cardiac interventions in select COVID-19 patients with refractory arrhythmias.
Abstract:
A 46-year-old woman was admitted with coronavirus disease-2019 infection. Symptomatic sinus bradycardia occurred, followed by congestive heart failure. Therapeutics such as isoproterenol, theophylline, and cilostazol could not safely improve her symptoms. She underwent pacemaker implantation 53 days after admission. Atrial pacing remained was at 60% after 6 months.
Related Concept Videos
ECG Interpretation of Arrhythmias I: Sinus Arrhythmias
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism,...
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Decreased pulse rate
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
Cardiomyopathy II: Dilated Cardiomyopathy
Conduction System of the Heart
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...

